ストックスクリーナーアプリを入手
37.27
2.36%
0.86
アフターアワーズ：
37.27
Harmony Biosciences Holdings Inc (HRMY) 最新ニュース
Zacks.com featured highlights include Harmony Biosciences, Adecoagro, Sociedad Quimica y Minera de Chile, Angi and PHINIA - The Globe and Mail
Movement Recap: Is AT T Inc forming a double bottom2025 Market Trends & Fast Gain Swing Alerts - baoquankhu1.vn
5 Value Picks Amid AI-Driven Tech Sell-Off & U.S.-Iran Tensions - TradingView
Avoiding Lag: Real-Time Signals in (HRMY) Movement - Stock Traders Daily
Harmony Biosciences Makes The Grade (NASDAQ:HRMY) - Seeking Alpha
Zacks.com featured highlights include Harmony Biosciences, Universal Health Services, Concentrix and Global Payments - Yahoo Finance
CFO’s Full Share Exit Contrasts With Harmony’s Positive WAKIX Growth Story - Yahoo! Finance Canada
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q3 2025 Earnings Call Transcript - MSN
Is Harmony Biosciences (HRMY) Pricing Reflect Its Cash Flow Potential After Recent Share Weakness - Sahm
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Short Interest Update - MarketBeat
Harmony Biosciences Chief Financial Officer Sells Shares Again After Previous Exit From Company Equity - AOL.com
Capital Management Corp VA Sells 29,654 Shares of Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Harmony Biosciences CFO Fully Exits Equity Ownership - intellectia.ai
Harmony Biosciences' CFO Sells All of His Insider Shares, Worth $752,800 - Yahoo Finance
Harmony Biosciences' CFO Sells All of Her Insider Shares, Worth $752,800 - The Motley Fool
Is Harmony Biosciences (HRMY) a Solid Growth Stock? 3 Reasons to Think "Yes" - sharewise.com
Hussman Strategic Advisors Inc. Reduces Stock Position in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Insider Sell: Sandip Kapadia Sells Shares of Harmony Biosciences Holdings Inc (HRMY) - GuruFocus
Sandip Kapadia Sells 3,746 Shares of Harmony Biosciences (NASDAQ:HRMY) Stock - MarketBeat
How Harmony Biosciences Can Prove Its Skeptics Wrong - Finviz
What’s the analyst consensus on Harmony Biosciences Holdings Inc.Earnings Beat & AI Powered Market Entry Ideas - mfd.ru
Harmony Biosciences: Still Undervalued But Unappealing Risk/Reward (Downgrade) - Seeking Alpha
Is Harmony Biosciences (HRMY) Attractive After Recent Price Weakness And DCF Upside Potential? - Yahoo Finance
Evaluating Harmony Biosciences (HRMY) Valuation After Stronger Fundamentals And Breakout Signals - Yahoo Finance
Harmony Biosciences Holdings (HRMY) Investor Outlook: A Promising 24.34% Upside Potential - DirectorsTalk Interviews
Harmony Biosciences' Sales and Profits Have Soared. Why Hasn't Its Stock Followed? - Finviz
Harmony Biosciences Holdings, Inc. $HRMY Shares Bought by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
Did Stronger Fundamentals and Bullish Technicals Just Shift Harmony Biosciences Holdings' (HRMY) Investment Narrative? - Yahoo Finance
How A New Price Target Is Reshaping The Story For Harmony Biosciences Holdings (HRMY) - Yahoo Finance
Assessing Harmony Biosciences (HRMY) Valuation As Growth, Financial Strength And Technical Signals Attract Investors - Sahm
I Was Shocked to Find This Value-Priced Biotech Growth Stock - Finviz
HRMY or ARGX: Which Is the Better Value Stock Right Now? - Yahoo Finance
Should Value Investors Buy Harmony Biosciences (HRMY) Stock? - Yahoo Finance
Harmony Biosciences (NASDAQ:HRMY) Raised to "Strong-Buy" at Zacks Research - MarketBeat
Harmony’s WAKIX Surges Toward Blockbuster Status as Revenue Nears $1 Billion - MyChesCo
Discipline and Rules-Based Execution in HRMY Response - Stock Traders Daily
Stock Recap: Can Harmony Biosciences Holdings Inc reach all time highs this yearMarket Sentiment Report & Short-Term Trading Alerts - baoquankhu1.vn
Harmony Biosciences CFO Kapadia sells $752k in stock By Investing.com - Investing.com Nigeria
Harmony Biosciences (NASDAQ:HRMY) CFO Sells $752,919.12 in Stock - MarketBeat
Harmony Biosciences CFO Kapadia sells $752k in stock - Investing.com
Earnings Beat: Is Harmony Biosciences Holdings Inc part of any ETF2025 Key Highlights & AI Powered Market Trend Analysis - baoquankhu1.vn
Harmony Biosciences Projects WAKIX Revenue to Surpass $1 Billion in 2026 - Sleep Review
Harmony Biosciences stock drops after ZYN002 exit as 2026 Wakix sales outlook tops $1 billion - TechStock²
HRMY: WAKIX nears blockbuster status as pipeline and commercial expansion drive growth into 2026 - TradingView — Track All Markets
Harmony Biosciences (NASDAQ:HRMY) Stock Price Down 7.4%Here's Why - MarketBeat
Harmony Biosciences (HRMY) is an Incredible Growth Stock: 3 Reasons Why - sharewise.com
Buy Signal: Is Harmony Biosciences Holdings Inc. stock a buy before product launchesEarnings Miss & Precise Entry and Exit Recommendations - Bộ Nội Vụ
Harmony Biosciences projects 2026 WAKIX revenue to exceed $1 billion By Investing.com - Investing.com Nigeria
Harmony Biosciences Guides to Over $1 Billion in WAKIX® Revenue in 2026; Advancing Robust Late-Stage Pipeline With Potential for Long-term Value Creation - BioSpace
Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $37 at Goldman Sachs - StreetInsider
Harmony Biosciences forecasts WAKIX revenue to exceed $1 billion in 2026 - StreetInsider
Harmony Biosciences projects 2026 WAKIX revenue to exceed $1 billion - Investing.com
J.P. Morgan Healthcare Conference - MarketScreener
0.23%
1.25%
大文字化:
|
ボリューム (24 時間):